{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-023538","form_type":"8-K","ticker":"XAIR","cik":"0001641631","company_name":"Beyond Air, Inc.","filed_at":"2025-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.025474+00:00","generated_at":"2026-05-16T19:52:09.884929+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Beyond Air Q2 revenue up 128% to $1.8M; net loss narrows; secures $32M financing","bullets":["Revenue $1.8M (+128% YoY); net loss ($7.9M) ($1.25/share) vs. ($13.4M) ($5.67/share).","Secured $32M capital ($12M note, 15%, 24-month maturity + $20M equity line); proforma cash $22.9M, runway into 2027.","Appointed Bob Goodman (Board member) as Interim CCO; David Webster departed.","Updated FY2026 revenue guidance to $8-$10M; achieved MDSAP certification; patent allowance for Gen2 LungFit PH.","International distribution network expanded to 35 countries; Phase 1a UNO trial completed with median survival >23 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-023538","json":"https://secwatch.observer/filing/0001493152-25-023538.json","markdown":"https://secwatch.observer/filing/0001493152-25-023538.md","text":"https://secwatch.observer/filing/0001493152-25-023538.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225023538/0001493152-25-023538-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641631/000149315225023538/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:52:09.884929+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}